Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Hey! I'd love to hear your thoughts, send me a voice note.

One missing line on a Good Faith Estimate can hand a patient a $400 dispute against you. Under the No Surprises Act's patient-provider dispute resolution rule, the patient is structured to win.

This Deep Dive unpacks how the GFE rule actually applies to PMHNP cash-pay and out-of-network practices in 2026: what counts as the convening provider, when the three-day clock starts, which CPT codes have to appear, and the exact $400-over-the-estimate threshold that triggers binding arbitration.

You will come away with:

- The line items HHS-OIG looks for on a compliant GFE

- The "good-faith" boundary new PMHNPs keep tripping over

- A pre-visit workflow that closes the $400 dispute door before it opens

Full post with the templates and citations: https://psychnpfellowship.com/good-faith-estimate-pmhnp-private-practice-2026/

Hey! I'd love to hear your thoughts, send me a voice note.

Prior authorization is eating one full clinical day a week from psychiatric NPs — and the new CMS rule that took effect January 1 explicitly carves out the prescription drugs PMHNPs file PAs for every day. Two hosts walk through the 2026 playbook: why psychiatry triggers PA on 57 percent of services versus 30.7 percent for other specialties, the stepped-care denial trap and the five-field documentation fix that beats it, the four-tier intake-to-appeal workflow that drops PA letter time from 22 minutes to 4, and the appeals math most clinicians miss — roughly 75 percent of Medicare PA denials get overturned, yet most PMHNPs never appeal. Worth a listen for any new or early-career PMHNP losing Friday afternoons to insurance portals. Full post: https://psychnpfellowship.com/pmhnp-prior-authorization-playbook-2026/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack How to Build a Referral Network as a New PMHNP: A Practical Guide.

A strong referral network is the difference between a thriving PMHNP practice and one that struggles to fill appointment slots. The most reliable referral sources are therapists, primary care providers, and other PMHNPs. This guide covers exactly how to build, maintain, and grow these relationships from scratch.

Read the full post: https://psychnpfellowship.com/build-referral-network-new-pmhnp-practical-guide/

Hey! I'd love to hear your thoughts, send me a voice note.

Two-thirds of new PMHNPs are eligible for federal loan forgiveness. Most never apply.

This Deep Dive walks through five 2026 programs that can stack to roughly $80,000 tax-free: the NHSC Loan Repayment Program (up to $50K in behavioral-health HPSAs), the NHSC SUD Workforce LRP (up to $80K over three years), the Indian Health Service LRP (up to $50K serving tribal communities), PSLF after the July 1, 2026 final rule, and the state-level programs Pew flagged as worth applying for first.

You will come away knowing:

- Which program pays the most for the least time commitment

- How to check whether a site counts as a Mental Health HPSA (137M+ Americans live in one)

- The 501(c)(3) employer rule PSLF kept intact in the new final rule

- Where Hochul's New York mental-health expansion and NC's $20M Licensed Workforce LRP fit in

Full breakdown with citations: https://psychnpfellowship.com/pmhnp-loan-forgiveness-2026-programs-worth-80k/

Hey! I'd love to hear your thoughts, send me a voice note.

A QTc above 500 ms triples the baseline risk of torsades de pointes — and most new PMHNPs cannot recite that number when asked. Two AI hosts walk through the 2026 protocol every PMHNP should run from memory: the three QTc thresholds (450 / 470 / 500 ms), the psychotropic risk hierarchy (IV haloperidol, ziprasidone, thioridazine, high-dose citalopram, methadone at the top; aripiprazole, sertraline, mirtazapine at the bottom), the polypharmacy stacking trap that quietly produces most outpatient torsades, and the four action levels — continue, dose-adjust + repeat, switch, or hold + cardiology. You will learn: (1) the three QTc tiers every PMHNP should run from memory before opening a chart; (2) the medication stack that quietly turns a clean baseline into a 500 ms reading; (3) the documentation phrasing that makes the chart defensible rather than dangerous. Full article: https://psychnpfellowship.com/qtc-monitoring-psychotropics-pmhnp-protocol-2026/

Hey! I'd love to hear your thoughts, send me a voice note.

Half of antipsychotic-induced akathisia gets misdiagnosed as anxiety on the first visit, and the standard reflex — push the antipsychotic dose — turns a fixable side effect into a treatment-ending one. In this Deep Dive, two AI hosts walk through the 2026 PMHNP decision tree: the Barnes Akathisia Rating Scale scoring protocol that takes five minutes at the visit (two minutes seated, two minutes standing), the mirtazapine-15-mg-versus-propranolol-10-30-mg-TID choice that the 2023 network meta-analysis sharpened, and the four-week minimum treatment window that prevents the relapse most prescribers cause when they stop the adjunct too soon. You will also learn the one question — are you moving more than you want to? — that pulls a third of missed cases out of the noise before the antipsychotic gets escalated. Full post and references: https://psychnpfellowship.com/akathisia-management-pmhnp-decision-tree-2026/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Managing Psychiatric Medication Side Effects: A PMHNP Clinical Decision Guide.

Side effect management is where PMHNPs earn patient trust and medication adherence. This clinical decision guide covers evidence-based strategies for the most common psychiatric medication side effects: metabolic syndrome, sexual dysfunction, sedation, akathisia, and GI disturbance, with specific intervention algorithms for each.

Read the full post: https://psychnpfellowship.com/managing-psychiatric-medication-side-effects-pmhnp-guide/

Hey! I'd love to hear your thoughts, send me a voice note.

Up to 56% of patients tapering antidepressants get withdrawal symptoms, and most PMHNP programs still teach the half-pill method that drives those symptoms. This episode breaks down the hyperbolic tapering approach that's becoming the 2026 standard.

You'll hear:

- Why receptor occupancy stays high at low doses, so 20→10 mg feels mild but 5→0 mg crashes patients

- How to build a hyperbolic schedule using liquid suspensions or compounded mini-doses (and what to do when the pharmacy pushes back)

- The patient-facing language that keeps people on the plan instead of cold-turkeying when discontinuation symptoms hit at week three

Full protocol, dosing tables, and the timeline script: https://psychnpfellowship.com/hyperbolic-antidepressant-tapering-pmhnp-protocol-2026/

The Deep Dive with Lindsay Hill, DNP, PMHNP — two AI hosts unpacking the blog for new and early-career PMHNPs.

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Telehealth Best Practices for PMHNPs: Beyond the Basics in 2026.

Telehealth psychiatric care has matured beyond the pandemic-era pivot into a sophisticated delivery model with its own best practices. This guide covers advanced telehealth techniques for PMHNPs including virtual clinical assessment nuances, technology optimization, patient engagement strategies, and compliance considerations for 2026.

Read the full post: https://psychnpfellowship.com/telehealth-best-practices-pmhnp-2026-guide/

Hey! I'd love to hear your thoughts, send me a voice note.

Bipolar depression is not unipolar depression with mood swings. The algorithm is different, the risks are different, and the trap most new PMHNPs fall into — adding an SSRI to a patient labeled depressed who is actually bipolar — can flip a stable patient into mania within weeks. This Deep Dive walks through the 2026 first-line algorithm: when to reach for lurasidone versus quetiapine, the role of cariprazine and lumateperone, why lithium and lamotrigine still belong on the list, and the exact decision tree for patients who failed the first agent. We also cover the screening miss that causes most "treatment-resistant depression" referrals — patients with bipolar II who got missed in a 25-minute intake — and the three questions that catch them every time.

Based on the full guide at psychnpfellowship.com/bipolar-depression-treatment-algorithm-pmhnp-2026/